#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14230	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2224	636.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1756	1756	T	733	T,C	689,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14230	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2224	636.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1490	1490	C	816	C	776	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14230	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2224	636.4	0	HET	.	.	.	A726G	.	726	726	A	1032	1032	A	798	A,G	556,210	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25272	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3721	677.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1783	1783	A	839	A	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25272	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3721	677.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2417	2417	C	794	C,A	750,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25272	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3721	677.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2491	2491	A	808	A	776	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25272	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3721	677.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3043	3043	C	734	C	697	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	35486	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1589	2222.7	0	.	p	.	0	P12S	NONSYN	34	36	CCC	421	423	TCC	2907;2915;2937	T;C,A,T;C,A	2769;2773,1,1;2791,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	G5V	NONSYN	13	15	GGT	326	328	GTT	91;89;88	G;T;T	89;84;86	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	E12K	NONSYN	34	36	GAA	347	349	AAA	113;116;117	A;A;A	109;112;112	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	F31L	NONSYN	91	93	TTT	404	406	TTG	164;164;165	T;T;G,T	153;153;153,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	437	439	CAA	214;212;213	C;A;A	202;200;200	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	S75P	NONSYN	223	225	TCC	536	538	CCT	173;175;174	C;C;T,C	160;163;162,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	V87A	NONSYN	259	261	GTA	572	574	GCA	150;149;148	G,A;C;A,G	146,1;144;143,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	V130L	NONSYN	388	390	GTC	701	703	CTC	182;182;185	C;T;C	168;165;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	R135C	NONSYN	403	405	CGC	716	718	TGT	189;189;186	T;G;T	170;178;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	T137A	NONSYN	409	411	ACG	722	724	GCG	190;190;193	G;C,G;G	179;174,1;180	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	764	766	AAG	198;198;202	A;A;G	190;192;194	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	T152N	NONSYN	454	456	ACC	767	769	AAT	201;202;204	A;A;T	195;195;196	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	F218L	NONSYN	652	654	TTT	965	967	TTG	149;148;145	T;T;G	143;142;138	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	995	997	AGC	130;132;131	A;G;C	128;129;128	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1064	1066	CTG	98;97;97	C;T;G	92;90;91	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1070	1072	TCC	96;95;94	T;C;C	93;88;92	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1085	1087	GTG	110;111;114	G;T;G	103;102;106	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1622	folP	852	852	93.78	folP.l15.c17.ctg.1	1540	104.8	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1136	1138	GCG	159;158;155	G;C;G	149;147;147	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5040	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3505	143.4	1	SNP	p	S91F	0	.	.	271	273	TCC	629	631	TCC	161;160;162	T;C,T;C	151;149,1;151	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5040	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3505	143.4	1	SNP	p	D95G	0	.	.	283	285	GAC	641	643	GAC	163;164;164	G;A,G;C	152;150,1;152	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5040	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3505	143.4	1	SNP	p	D95N	0	.	.	283	285	GAC	641	643	GAC	163;164;164	G;A,G;C	152;150,1;152	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	1622	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1365	118.2	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	785	785	T	198	T	191	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	876	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1023	84.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1539	1541	ATC	215;215;215	A;T;C	203;202;201	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1692	1694	GCA	185;185;187	G,A;C;A	173,2;171;172	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	188;189;190	G;A;C	181;180;183	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	1	SNP	p	S87W	0	.	.	259	261	AGT	648	650	AGT	189;189;189	A;G;T	178;178;176	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	1	SNP	p	S87R	0	.	.	259	261	AGT	648	650	AGT	189;189;189	A;G;T	178;178;176	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	1	SNP	p	S87I	0	.	.	259	261	AGT	648	650	AGT	189;189;189	A;G;T	178;178;176	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4948	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3183	155.1	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	185;185;185	T;C;C	174;176;174	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4212	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2781	150.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1632	1634	GGC	203;203;202	G;G;C	195;192;190	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1203	1205	GCA	212;211;213	G;C;A	199;198;200	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1206	1208	ATC	210;211;210	A;T;C	200;201;199	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1218	1220	GTG	202;203;206	G;T;G	194;193;197	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1218	1220	GTG	202;203;206	G;T;G	194;193;197	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1722	1724	ACC	202;198;199	A;C;C	192;188;194	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1776	1778	GCG	191;191;191	G;C;G	164;147;154	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1776	1778	GCG	191;191;191	G;C;G	164;147;154	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1899	1901	GGT	155;151;153	G;G;T	148;146;147	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1908	1910	GGC	150;151;150	G;G;C	142;144;141	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3770	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2351	159.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1926	1928	CCG	135;138;142	C,G;C,T,G;G	101,2;105,1,1;111	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5536	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3120	177.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2270	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1893	119.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	340	342	GGC	165;162;160	G;G;C	159;155;155	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2270	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1893	119.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	165	C,T	155,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2756	porB1b	1035	1035	98.47	porB1b.l15.c30.ctg.1	1360	197.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	562	564	CTT	216;215;216	C;T;T	208;209;208	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2756	porB1b	1035	1035	98.47	porB1b.l15.c30.ctg.1	1360	197.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	790	790	T	203	T	194	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2756	porB1b	1035	1035	98.47	porB1b.l15.c30.ctg.1	1360	197.5	1	SNP	p	G120K	0	.	.	358	360	GGT	517	519	GGT	203;204;205	G;G;T	193;194;187	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2756	porB1b	1035	1035	98.47	porB1b.l15.c30.ctg.1	1360	197.5	1	SNP	p	A121D	0	.	.	361	363	GCC	520	522	GCC	205;204;204	G;C;C	190;191;190	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2756	porB1b	1035	1035	98.47	porB1b.l15.c30.ctg.1	1360	197.5	1	SNP	p	A121N	0	.	.	361	363	GCC	520	522	GCC	205;204;204	G;C;C	190;191;190	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10158	rpoB	4179	4179	99.95	rpoB.l15.c17.ctg.1	4809	210.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1142	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1038	109.5	1	SNP	p	V57M	1	.	.	169	171	ATG	523	525	ATG	232;232;234	A;T;G	215;215;216	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
